Transgender hormone therapy (male-to-female) medical professional. Inducers of CYP3A4 and other cytochrome P450 enzymes can reduce the effects of MTF HRT. A variety of different sex-hormonal medications are used in feminizing hormone therapy for transgender women. These include estrogens to induce feminization and suppress testosterone levels; antiandrogens such as androgen receptor antagonists, antigonadotropins, GnRH modulators, and 5α-reductase inhibitors to further oppose the effects of androgens like testosterone; and progestogens for various possible though uncertain benefits. Estrogens are the major sex hormones in women, and are responsible for the development and maintenance of feminine secondary sexual characteristics, such as breasts, wide hips, and a feminine
Fraternal birth order and male sexual orientation studies have demonstrated that the fraternal birth order effect does not operate through social or postnatal (e.g., learning or rearing or environmental) mechanisms; rather it is biological in nature and operates prenatally. It is also known that the fraternal birth order effect on male sexual orientation is unaffected by family dynamics, living with older brothers or learning. Fraternal birth order and male sexual orientation A correlation between fraternal birth order and male sexual orientation has been suggested by research. Ray Blanchard identified the association and referred to it as the fraternal birth order effect. In several studies, the observation is